Trials / Conditions / Metastatic Prostate Neuroendocrine Carcinoma
Metastatic Prostate Neuroendocrine Carcinoma
4 registered clinical trials studyying Metastatic Prostate Neuroendocrine Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT NCT06062745 | Brigham and Women's Hospital | Phase 1 |
| Recruiting | Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Pr NCT05691465 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Pr NCT04709276 | Andrew J. Armstrong, MD | Phase 2 |
| Active Not Recruiting | Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of NCT04592237 | M.D. Anderson Cancer Center | Phase 2 |